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Abstract: Background: Cholesterol has a pivotal role in human physiology, exerting both structural 
and functional activity. However, higher blood cholesterol levels, especially low-density lipopro-
tein cholesterol (LDL-C), are a major cardiovascular risk factor. Therefore, special attention has been 
given to the effect of dietary factors in influencing LDL-C blood levels. In particular, much research 
has focused on dairy products, since they are a main component of different dietary patterns world-
wide. A large body of evidence did not support the hypothesis that dairy products significantly 
increase circulating LDL-C, but no definitive data are available. Hence, we aimed to assess the rela-
tionships among LDL-C, habitual dairy food intake and anthropometric variables in a cohort rep-
resentative of the general population in a Mediterranean area. Methods: We evaluated 802 healthy 
adults included in the ABCD_2 (Alimentazione, Benessere Cardiovascolare e Diabete) study 
(ISRCTN15840340), a longitudinal observational single-center study of a cohort representative of 
the general population of Palermo, Sicily. The habitual intake of dairy products was assessed with 
a validated food frequency questionnaire, and LDL-C serum levels and several anthropometric pa-
rameters were measured. Results: The group with high LDL-C serum concentrations (≥130 vs. <130 
mg/dL) exhibited higher age, body mass index (BMI), waist-to-hip ratio (WHR), body fat percent-
age, systolic and diastolic blood pressure, carotid intima-media thickness and glycated hemoglobin. 
The habitual diet was not different between the groups in terms of macronutrient, cholesterol, egg 
and dairy food intake, with the exception of the weekly number of portions of milk (higher in the 
low LDL-C group vs. the high LDL-C group) and ricotta cheese (higher in the high LDL-C group 
vs. the LDL-C group). No significant correlation was found between LDL-C blood levels and the 
habitual intake of dairy products or the dietary intake of cholesterol and fats. The multivariate re-
gression analyses (R2 = 0.94) showed that LDL-C blood levels were significantly associated with the 
habitual intake of milk (p < 0.005) and ricotta cheese (p < 0.001) and with BMI (p < 0.001). Conclusion: 
Our study reported that total dairy food consumption was not correlated with LDL-C blood levels. 
However, multivariate analyses showed an inverse association between serum LDL-C and milk 
intake as well as a positive association between ricotta cheese intake and LDL-C concentrations. 
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More studies are needed to better characterize the relationship between dairy products and circu-
lating LDL-C. 
Keywords: dairy; milk; ricotta; LDL; cholesterol 
 
1. Introduction 
Cardiovascular diseases (CVDs) are the main cause of death worldwide, representing 
nearly 25% of all deaths in both developing and developed countries [1]. The economic 
burden of CVD is enormous, with costs that are estimated to be more than 200 billion 
dollars per year, both in Europe [2] and in the United States [1]. One of the major modifi-
able risk factors for CVD is the concentration of blood cholesterol and its lipoprotein sub-
classes, since the deposition of cholesterol in the arterial walls was demonstrated as the 
key initiating event of atherosclerosis [3]. In particular, blood levels of low-density lipo-
protein cholesterol (LDL-C) are mainly responsible for atherosclerosis promotion and pro-
gression [4], and the strong association between serum LDL-C and CVD is well acknowl-
edged [5]. Therefore, targeting low LDL-C serum levels is a cornerstone for cardiovascular 
prevention and treatment [6]. Cholesterol supply is determined by both dietary intake 
(exogenous production) and de novo biosynthesis (endogenous production), the former 
accounting for approximately 30% of total circulating cholesterol [7]. Hence, dietary in-
take has a pivotal role in influencing serum LDL-C concentrations, and many studies have 
demonstrated that dietary patterns are associated with blood lipid profiles [8]. In particu-
lar, dairy products include foods with high nutritional value that are consumed world-
wide as fundamental components of several dietary patterns. Therefore, special attention 
has been given to the habitual intake of dairy foods and the effects on serum LDL-C con-
centrations [9,10]. In particular, although the bulk of the studies reported that dairy food 
intake was not associated with higher LDL-C serum concentrations [11–16], no definitive 
and unequivocal data are available since other studies found a positive [17] or even a neg-
ative association [18]. Factors as age [11], gender [12], concomitant CVD, diabetes or use 
of cholesterol-lowering drugs [14–16] might be potential confounding factors in studies 
exploring the influence of dietary factors on cholesterolemia. Consequently, more studies 
are required, particularly those investigating large cohorts representative of the general 
healthy population, to better characterize this relationship, especially considering the con-
sequences for human health and the significant substantial resources invested in facing 
CVD. Therefore, our aim was to investigate the relationship between LDL-C serum con-
centrations, anthropometric parameters and the habitual intake of dairy foods in a cohort 
of randomly selected healthy adults living in the Mediterranean area of Palermo (Sicily, 
Italy). 
2. Materials and Methods 
2.1. Participants 
The Nutrition, Cardiovascular Wellness and Diabetes (ABCD_2) project 
(ISRCTN15840340) is a longitudinal observational single-center study of a cohort repre-
sentative of the general population living in Palermo, the largest city in Sicily (Italy), with 
a population of 674,742. The ABCD study cohort was recruited in 2011, as previously de-
scribed [19]. In particular, the inclusion criteria were participants aged >18 years who re-
sided in Palermo. The demographic characteristics of the ABCD cohort were similar to, if 
not overlapping with, those of the general population of the same age range (18–90 years) 
living in Palermo in 2011, as presented elsewhere [20]. The original cohort was recontacted 
(telephone, e-mail, letter) in 2015, and those who agreed to participate in the study were 
asked to come to the Metabolism and Clinical Nutrition Laboratory of the Department of 
Internal and Specialized Medicine at the University of Palermo and were reexamined 
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from 21 March to 31 July. Each participant was given the opportunity to present a relative 
or friend as a new participant in the study, but the number of new participants was limited 
to the first 300 people. The demographic characteristics of the ABCD_2 cohort were not 
significantly different from those of the ABCD_1 cohort, as presented elsewhere [21]. Lim-
ited to the present study, people with known diabetes, coronary heart disease, previous 
stroke and current use of statins or other lipid-lowering drugs were excluded from calcu-
lations. 
The institutional Ethics Committee (“Palermo 1” of the Policlinico “P. Giaccone” Uni-
versity Hospital, 3 November 2014, ref: March 2015) approved the study protocol, and 
each participant signed an approved informed consent form. 
Participants were administered questionnaires on demographic characteristics, the 
presence of chronic diseases and pharmacologic treatment. Additionally, a Food Fre-
quency Questionnaire and a questionnaire on habitual physical activity were adminis-
tered. All participants underwent anthropometric, body composition, and carotid intima-
media thickness (c-IMT) measurements, and a postabsorptive fasting blood venous sam-
ple was obtained for laboratory tests. 
2.2. Food Frequency Questionnaire 
Half-quantitative habitual intake of different foods during the past 12 months was 
assessed with a previously validated local population medium-length Food Frequency 
Questionnaire (FFQ) as reported elsewhere [22]. Specifically, participants were asked by 
trained dietitians about their consumption of 36 different food items and were also asked 
to indicate their usual rate of consumption, choosing from seven frequency categories, 
ranging from “never” or “less than once a week” to “7 times per week.” The food items 
were categorized as drinks, cow milk and dairy products, meat-fish-eggs, cereals, vegeta-
bles-legumes-fruit, fat dressing, and other (sweets, fried foods and fast food). For coffee, 
alcoholic and soft drinks, the amount in terms of cups/glasses was also specified. In most 
instances, a reference food was considered for different items, and food photographs were 
used to help in portion-size description [23]; requested data referred to the last year. Data 
are expressed as the number of portions consumed (daily or weekly) of each food and as 
an estimation of diet composition. 
Additionally, a specifically developed and validated questionnaire was administered 
to define the individual level of habitual physical activity (HPA) as described elsewhere 
[21]. Briefly, on the basis of both the intensity and frequency of physical exercise, 4 differ-
ent levels of HPA were defined: (a) very low (no habitual exercise); (b) low (walks of 20–
30 min at least 3 times a week); (c) medium (scheduled physical activity 1–3 times a week, 
or walks >30 min at least 3 times a week); and (d) high (scheduled physical activity >3 
times a week or competitive sport activity or heavy job activity). For the purposes of the 
study, sedentary people were defined as those with very low or low HPA, and nonseden-
tary people were defined as those with medium or high HPA. 
2.3. Measurements 
Height and body weight were measured with participants lightly dressed and with-
out shoes (SECA); the body mass index (BMI) was calculated as body weight (kg)/height2 
(m2). Body circumferences were measured at the umbilicus (waist circumference) and at 
the most prominent buttock level (hip circumference); the ratio (waist-to-hip ratio [WHR]) 
was used as an indirect index of body fat distribution [24]. Systolic and diastolic arterial 
blood pressure (two measurements obtained at 5-minute intervals in a seated position) 
and heart rate (Omron M6; Omron Healthcare Co; Matsusaka, Mie, Japan) were measured 
by physicians or dietitians according to standardized procedures. Body composition in 
terms of fat mass (FM) and fat-free mass (FFM) was estimated using bioelectrical imped-
ance analysis (BIA; BIA-101 Anniversary, Akern; Florence, Italy) following the manufac-
turer’s equations, as previously described [25]. 
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2.4. Laboratory Analysis 
Participants underwent blood sampling for the assessment of blood chemistry and 
hormonal parameters. For each participant, a blood sample was frozen and stored at 
−80°C for subsequent measurements. Fasting plasma glucose (FPG), total cholesterol, 
high-density lipoprotein cholesterol (HDL-C), triglycerides (Tg), uric acid and creatinine 
concentrations were ascertained using standard clinical chemistry methods (Glucosio HK 
UV; Colesterolo tot. Mod P/D; Colesterolo HDL gen 3 mod P/917; Trigliceridi; Acido urico 
MOD P/917; Creatinina enzimatica; Roche Diagnostics; Monza, Italy). Basal insulin con-
centrations (Elecsys insulina; Roche Diagnostics; Monza, Italy), high sensitivity c-reactive 
protein (hs-CRP; B-analyst hs-CRP; Menarini diagnostics; Florence, Italy) and glycated 
hemoglobin (HbA1c; B-analyst HbA1c; Menarini diagnostics; Florence, Italy) were also 
measured. LDL-C serum concentration was calculated with Friedewald’s formula [26], 
and HOMA-IR was calculated as described by Matthews et al. [27]. 
2.5. Statistical Analysis 
Data are reported as the means ± SD for continuous variables and as percentages for 
categorical variables. Normal distribution of each variable was tested using the Shapiro–
Wilk test, variables with skewed distribution were log-transformed when appropriate. 
LDL-C values were also categorized as “<130” and “≥130” mg/dL according to the values 
that were historically considered normal for primary prevention of cardiovascular events 
[28]. Student’s t-test for unpaired data was used to compare continuous variables between 
two groups. The χ2 test was used to compare categorical variables. Pearson’s r correlation 
coefficients were calculated to explore the associations among variables. Factors that were 
significantly correlated with LDL-C values were included in stepwise multivariate regres-
sion (backward model selection) analysis. A two-tailed p value < 0.05 was considered sig-
nificant. All analyses were performed with Systat (Windows version 13.0; San Jose, CA, 
USA). 
3. Results 
A total of 1033 participants (415 males and 618 females) were initially selected. 
Among these, 225 participants were excluded because of type 2 diabetes, coronary heart 
disease, previous stroke or use of statins or other lipid-lowering drugs (including fibrates, 
ezetimibe, proprotein convertase subtilisin/kexin type 9 inhibitors, and omega-3 fatty ac-
ids) in different combinations, four cases were excluded because of incomplete data, and 
2 cases were excluded because of pregnancy. Finally, a total of 802 participants were eval-
uated. The physical, biochemical, and clinical characteristics of the participants divided 
into two groups according to LDL-C blood concentrations (<130 and ≥130 mg/dL) are pre-
sented in Table 1. The group with high LDL-C blood concentrations exhibited higher age, 
BMI, WHR, body fat, systolic and diastolic blood pressure, c-IMT and glycated hemoglo-
bin. The group with high LDL-C also had a higher prevalence of menopausal women (64.1 
vs. 35.9%; p < 0.001). Concerning the habitual diet, as summarized in Table 1, no difference 
was observed between the groups in terms of the intake of macronutrients, cholesterol, 
eggs and dairy foods with the exception of the weekly number of portions of cow milk 
and ricotta cheese that were higher in the low LDL-C group and the high LDL-C group, 
respectively. No difference was observed considering the number of portions consumed 
of fresh or aged cheese, yogurt, or mozzarella cheese. A similar number of people did not 
habitually consume milk in the two groups (37.0% vs. 44.9%, low vs. high LDL-C group; 
p= 0.10); furthermore, no difference was observed concerning the use of whole milk (6.1 
vs. 5.2%), low-fat milk (53.5 vs. 45.5%) and skimmed milk (3.4 vs. 4.4%). The variables 
BMI, fat mass, waist and hip circumferences, habitual intake of cholesterol, fats, milk and 
ricotta cheese were not normally distributed and, consequently, log transformed. Simple 
correlations between LDL-C blood concentrations and anthropometric and diet variables 
are presented in Table 2. The multiple regression analysis demonstrated that age, BMI, 
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habitual intake of milk and ricotta cheese (but not daily cholesterol intake, fat mass, waist 
circumference and WHR) were independently associated with blood LDL-C concentra-
tions (Table 3). 
Table 1. Physical and clinical characteristics and dietary habits of the cohort according to the LDL-
cholesterol blood levels. 
 LDL-Cholesterol (mg/dL)  
 <130 
n = 453 
≥130 
n = 349 
p * 
Age (years) 46  15 55  11 <0.001 
Male sex (%) 36.0 39.5 0.30 
Current smokers (%) 14.6 16.8 0.24 
Body weight (kg) 74.0  17.1 75.3  15.1 0.28 
BMI (kg/m2) 27.6  5.9 28.5  4.9 <0.05 
Fat mass (%) 28.5  9.8 30.0  8.7 <0.05 
Waist circumference (cm) 93.7  14.2 97.3  12.4 <0.001 
WHR 0.89  0.08 0.92  0.08 <0.001 
c-IMT (mm) 0.55  0.17 0.64  0.18 <0.001 
Blood pressure (mmHg)    
systolic 119  18 125  16 <0.001 
diastolic 78  10 81  10 <0.001 
Level of HPA:    
Low (very low + low) 55.1 57.4 0.14 
Habitual intake of:    
Lipids (% of EI) 30.5  6.4 30.5  6.4 0.97 
Cholesterol (mg/day) 217  89 206  73 0.06 
Milk (n. portions/week) 3.4  3.9 2.9  3.2 <0.05 
Cheese (n. por-
tions/week) 
4.2  2.3 4.3  2.4 0.83 
Ricotta cheese (n. por-
tions/week) 
0.7  0.6 0.8  0.7 <0.05 
Total dairy products (n. 
portions/week) 
9.6  5.1 9.3  5.0 0.41 
Eggs (n./week) 1.2  0.9 1.2  0.9 0.93 
Blood concentrations of:    
Glucose (mg/dL) 87.5  16.5 88.6  10.0 0.21 
HbA1c (%) 5.3  0.5 5.4  0.4 <0.001 
Insulin (µUI/mL) 9.4  5.7 9.8  5.9 0.27 
Cholesterol (mg/dL) 182  26 241  30 <0.001 
HDL-C (mg/dL) 62.6  17.0 60.7  16.1 0.11 
Cholesterol/HDL-C 3.1  0.8 4.2  1.0 <0.001 
Triglycerides (mg/dL) 85  54 108  51 <0.001 
LDL-C (mg/dL) 102  20 160  24 <0.001 
Uric acid (mg/dL) 4.7  1.2 5.0  1.3 <0.001 
HOMA-IR 2.10  1.40 2.21  1.37 0.28 
Mean  SD; * Student’s unpaired t-test or 2 when appropriate. BMI: body mass index; c-IMT: ca-
rotid intima-media thickness; EI: energy intake; HbA1c, glycated hemoglobin; HDL-C: high-den-
sity lipoprotein cholesterol; HOMA-IR: homeostatic model assessment of β-cell function and insu-
lin resistance; HPA: habitual physical activity; LDL-C: low-density lipoprotein cholesterol; WHR: 
waist-to-hip ratio. 
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Table 2. Simple correlations among LDL-C blood concentrations, anthropometric variables and 
the habitual intake of nutrients and dairy foods. 
 LDL-C Age Log BMI Log Waist Log Hip WHR FM % 
LDL-C - 
0.33 0.14 0.19 0.06 0.23 0.10 
(<0.001) (<0.001) (<0.001) (0.11) (<0.001) (<0.05) 
Log Fat intake (% 
of EI) 
0.02 0.02 0.02 −0.01 0.04 −0.07 −0.02 
(0.57) (0.58) (0.63) (0.67) (0.24) (0.07) (0.69) 
Log Cholesterol 
intake (mg/day) 
−0.07 −0.09 −0.04 −0.03 −0.02 −0.01 −0.03 
(0.07) (<0.05) (0.24) (0.44) (0.63) (0.67) (0.44) 
Log Milk (por-
tions/week) 
−0.10 0.01 −0.01 −0.03 0.002 −0.05 0.01 
(<0.01) (0.85) (0.69) (0.37) (0.97) (0.16) (0.79) 
Log Ricotta cheese 
(portions/week) 
0.12 0.03 −0.04 −0.01 −0.06 0.04 −0.07 




−0.02 0.04 0.04 0.06 0.06 0.03 0.03 
(0.56) (0.29) (0.24) (0.12) (0.10) (0.48) (0.47) 
Pearson correlation coefficients (r), p values in parenthesis. BMI, body mass index; EI, energy in-
take; FM, fat mass; LDL-C, low-density lipoprotein cholesterol; WHR, waist-to-hip ratio. 
Table 3. Multivariate stepwise (backward selection) regression analysis of factors correlated with 
blood LDL-cholesterol concentrations according to the data presented in Table 2. 
 Coefficients Standard Error p 
Age (years) 0.796 0.094 <0.001 
Log BMI (kg/m2) 27.792 1.511 <0.001 
Log Habitual intake of ricotta 
cheese (portions/week) 
8.538 2.491 <0.001 
Log Habitual intake of milk (por-
tions/week) 
−4.022 1.316 <0.005 
R2 = 0.94. Variables not in the model: sex, waist circumference, WHR, FM%. BMI, body mass index; 
FM, fat mass; WHR, waist-to-hip ratio. 
4. Discussion 
This study found that in a cohort of a general real-life population, habitual dairy food 
intake and LDL-C blood levels were not associated. However, we observed some excep-
tion. In fact, the habitual intake of cow milk was inversely associated with serum LDL-C 
concentrations, while that of habitual ricotta cheese was positively associated with LDL-
C. The lack of correlation between dairy products and LDL-C is not surprising, and other 
studies reported similar findings. Barr and colleagues showed that increasing milk con-
sumption did not increase LDL-C concentrations [11]. Similarly, Beavers et al. observed 
that 4 weeks of regular milk consumption did not increase LDL-C compared with soy 
milk beverages [12]. Furthermore, in a cohort of postmenopausal women, no significant 
difference in LDL-C blood levels was found between individuals consuming milk and 
those using a milk-free diet [14]. Again, Wade and colleagues analyzed a cohort of indi-
viduals randomized to consume a Mediterranean diet supplemented with dairy products 
and a low-fat diet, reporting no difference in circulating LDL-C between the two groups 
[15]. Conversely, another study reported that increasing dairy product consumption 
slightly, yet significantly, increased LDL-C levels [17]. Intriguingly, a negative association 
was also found between dairy product consumption and LDL-C serum levels [18]. How-
ever, a recent meta-analysis [13] that included nine randomized controlled trials (RCTs) 
reported that low-fat as well as high-fat dairy food diets did not significantly influence 
circulating LDL-C. Regarding milk intake, although many studies have investigated the 
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relationship between milk consumption and LDL-C concentrations, there are inconsisten-
cies. Our findings are in agreement with Rossouw and colleagues who reported that abun-
dant skim milk consumption significantly lowered LDL-C in a group of healthy adoles-
cents [29]. Similarly, a study evaluating a cohort of more than 3000 subjects reported that 
individuals with higher milk consumption had lower LDL-C blood levels [18]. Further-
more, it was demonstrated that increasing milk consumption induced no significant 
change in blood concentrations of LDL-C [11]. Comparable findings were obtained by 
Drouin-Chartier et al., who found that a milk-providing diet did not increase LDL-C se-
rum levels compared with a milk-free diet [14]. Similar results were obtained by Bard et 
al., who performed a RCT and demonstrated no correlation between LDL-C serum levels 
and milk-containing diets, even in comparison with vegetable fat-containing consumption 
[16]. Otherwise, to the best of our knowledge, there are no previous studies investigating 
ricotta cheese intake and LDL-C blood levels. Composition in terms of micro- and macro-
nutrients might account for the results previously described, since Lorenzen and Astrup 
hypothesized a calcium-induced mechanism of increased fecal fat and bile acid elimina-
tion [30] that might influence cholesterol levels by decreasing cholesterol absorption. 
However, this mechanism could not fully explain the different influences of milk and ri-
cotta cheese, since the latter has a significantly higher content of calcium in comparison to 
milk [31,32], so minerals and macronutrients might also influence serum blood lipids. 
First, it is important to note that ricotta has a greater phosphorus content than milk [31,32], 
and these higher levels might decrease the effect of calcium on cholesterol absorption 
through the calcium binding effect exerted by phosphorus itself. Even the sodium and 
potassium contents, lower and higher in milk, respectively [31,32], could have “a walk on 
part”, if any. Indeed, it was previously suggested that a lower sodium/potassium dietary 
intake ratio was correlated with decreased LDL-C blood levels [33]. Moreover, milk has a 
significantly lower content of lipids than ricotta, particularly saturated fatty acids (SFAs) 
[31,32], since it was observed that the influence of dietary SFAs on serum LDL-C was 
greater than that of cholesterol itself [34,35]. Furthermore, milk is richer in monounsatu-
rated fatty acids than ricotta [31,32], and it was clearly demonstrated that unsaturated 
fatty acids, when used in substitution of SFAs, reduced LDL-C concentrations [36,37]. In-
triguingly, although ricotta has a greater protein content than milk, its percentage of es-
sential amino acids is lower in comparison to milk [31,32], as it was speculated that the 
essential amino acid intake could contribute to reducing LDL-C [38,39]. It is conceivable 
that all the proposed mechanisms, if taken alone, could not be sufficient to account for the 
different data; however, if the sum is greater than the parts, the whole nutrient composi-
tion might, at least in part, explain why milk and ricotta cheese impinge on LDL-C levels 
so differently. Altogether, although many studies claimed that dairy products were not 
correlated with LDL-C concentrations, it is not possible to draw definitive conclusions 
concerning this relationship. One may conceive that several confounding factors, different 
criteria for cohort recruitment and the relatively short period of intervention trials could 
account for these discrepancies. Hence, more studies, particularly long-lasting longitudi-
nal and robust intervention studies, are warranted to fully elucidate this relationship. 
Additionally, we reported that LDL-C serum concentrations were not affected by di-
etary factors, including the intake of fats (as a percentage of total energy intake) or that of 
cholesterol in the diet. Many studies have investigated whether cholesterol intake influ-
ences serum LDL-C, but the data are still controversial. In addition, a possible confound-
ing factor might be that studies on this topic have a different prevalence of hyper- and 
hypo responders to dietary cholesterol. Two studies concerning a cohort of adult Chinese 
individuals reported that cholesterol intake accounted for increased LDL-C concentra-
tions [40,41]; however, neither study adjusted their models according to SFAs. According 
to two recent meta-analyzes, LDL-C serum concentrations were positively correlated with 
habitual cholesterol intake [42] and increasing the amount of cholesterol consumption was 
positively associated with an increase in circulating LDL-C levels [43]. Conversely, in 
agreement with our results, Lin and colleagues observed no association between LDL-C 
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blood levels and the habitual intake of dietary cholesterol [44], even after adjusting for 
SFAs. Interestingly, a recent survey carried out in a population cohort of nearly 40,000 
Koreans reported that dietary cholesterol was significantly correlated with circulating 
LDL-C, but remarkably, this correlation disappeared after adjusting for SFA intake [45]. 
A possible explanation for the lack of influence of dietary factors in our study might be 
that the cohort we investigated was living in a Mediterranean area with dietary habits, as 
suggested by the FFQ, that can be considered healthy. Overall, it seems impossible to 
clearly establish this relationship due to a number of confounding factors that might alter 
the final data. In fact, other macronutrients, such as SFAs, fiber or calcium, can signifi-
cantly influence LDL-C blood levels. This seems to be clearly demonstrated in the case of 
SFAs, which have been proven as pivotal determinants of serum LDL-C [34,35]. Moreo-
ver, previous data are also indicative of the presence of a significant threshold of choles-
terol intake impinging on the development of LDL-C hypercholesterolemia [46]. 
In agreement with previous observations [47–49], our study demonstrates that LDL-
C blood levels are independently associated with BMI, confirming that this is a possible 
contributing factor to the increased CV risk associated with obesity as suggested by the 
significantly higher values of c-IMT in the group with high LDL-C. 
Furthermore, we found that level of HPA was not correlated with serum LDL-C. Our 
results are consistent with data from Huffman and coll. who reported that sedentary over-
weight individuals undergoing aerobic exercise did not show reduced LDL-C concentra-
tions at the end of intervention [50], albeit they observed an improvement in LDL-C par-
ticle number and size [50]. On the contrary, Stefanick et al. reported that physical exercise 
was correlated with lower LDL-C blood levels [51] and overall, there is compelling evi-
dence that regular physical exercise reduces circulating LDL-C [6]. However, according 
to data reported till now exercise only slightly affects LDL-C blood levels [6] and this small 
effect could account, at least in part, for the lack of correlation in our study. Nonetheless, 
the general recommendation for dyslipidemia management is to increase physical exer-
cise [6]. 
This study has some strengths. The cohort recruited had characteristics similar, if not 
overlapping, to those of the general population. Additionally, we assessed habitual die-
tary patterns through a validated FFQ for the local population so that accuracy was 
granted as much as possible in investigating dairy food consumption. Moreover, our re-
sults should be scarcely influenced by confounding factors, since people with cardiovas-
cular diseases or type 2 diabetes that may induce individuals to modify their dietary hab-
its were excluded. 
Our study also has important limitations. Due to the cross-sectional design of the 
study, we could not demonstrate any cause–effect relationship. Moreover, despite the re-
semblance between the characteristics of our cohort and those of the general population, 
the modality of cohort enrollment did not allow us to conclude that our cohort was fully 
representative of the general population. Indeed, we did not consider genetic factors that 
could influence LDL-C levels [52]. Finally, we did not adjust for the energy intake data 
concerning the consumption of the different foods. However, the FFQ returns approxi-
mate values of habitual food intakes that in some instances must be considered proxy 
indicators of different aspects of habitual diet. The accuracy of this tool is not adequate to 
calculate/adjust exactly the habitual amount of foods/energy. 
5. Conclusions 
In this study, we did not find any correlation between habitual dairy food consump-
tion and serum LDL-C. However, we also reported that LDL-C blood levels were in-
versely and independently associated with cow milk intake, whereas the opposite oc-
curred with ricotta cheese consumption. We hypothesize that different micro- and macro-
nutrients in dairy products might account for this difference, especially SFA content. 
However, more studies, particularly robust RCTs assessing every aspect of dietary intake, 
are warranted to fully elucidate the relationship between LDL-C blood levels and dairy 
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foods. Given the significant influence of body size on LDL-C concentrations, it is im-
portant that future studies focus on maintaining unaltered body parameters while evalu-
ating the effect of dairy foods on circulating LDL-C. 
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